REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/07/2025
Back to search
Official data from USPTO
BIOPHARMACEUTICAL ACCELERATION MODEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOPHARMACEUTICAL ACCELERATION MODEL
ST13
US500000088428831Class
35, 41, 42, 44
Filing
88428831
Registration
6093742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/08/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
05/14/2019
Registration date
07/07/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2020
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/07/2019
First use in commerce
01/07/2019
Drawing code
4
Owner type
16
Owner location
Morrisville, NC
Examiner
ALAO, OREOLUWA
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Syneos Health, LLC
Representatives
Michael A. Geller DLA PIPER LLP (US)
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Strategic business consultingmarketing and advertisingconsultancy regarding public relations communications strategyinformation and data collectioncompiling and analyzing data and information for business purposesbusiness data analyticsanalyzing business data to understand and evaluate business performanceall of the aforementioned in the pharmaceuticalbiotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment advertising servicesadvertising clinical trials for the purpose of recruiting patientsplacing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for othersall in the pharmaceuticalbiotechnology and life sciences fields; business consulting in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalpharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting pharmaceutical and biotechnology companies with preparing and filing applications for new drugs with governmental regulatory bodies; promoting the exchange of health information within the pharmaceuticalbiotechnology and life sciences communities to promote patient adherence within the field of pharmaceuticalbiotechnology and life sciences clinical trials; extended clinical research services for otherscomputerized data management of clinical trials
Class 41
Education services in the field of pharmaceutical salesproviding non-downloadable webinarsproviding live workshopsproviding seminars through on-line non-downloadable videosproviding on-line non-downloadable electronic publications in the nature of articles and white papersproviding non-downloadable podcastsall the foregoing in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line non-downloadable electronic newsletters and bulletins in the pharmaceuticalbiotechnology and life sciences fields; educational servicesproviding courses offered through on-line non-downloadable videosnon-downloadable webinarslive workshopsproviding online non-downloadable electronic publications in the nature of articles and white papersproviding non-downloadable podcastsall the foregoing in the field of clinical trials
Class 42
Medical and scientific data analysis research services for othersconducting and analyzing clinical trials in the pharmaceuticalbiotechnology and life sciences fields; pharmaceutical drug development servicesdeveloping clinical trial methodologies; consulting services in the area of pharmaceutical product clinical testing; extended clinical research services for others for medical purposesbiostatistical analysis for scientific research purposespreclinical research in the field of pharmaceuticalsbiotechnologymedical sciencesdevelopment evaluationclinical feasibility assessment of protocols and patient recruitment strategiesrepairing flawed clinical trials and dossiersmedical and scientific research in the nature of conducting clinical trials for othersstrategic clinical research portfolio managementconsulting services for others in the project management of clinical research; extended clinical research services for others in the field of pharmaceuticalsbiotechnologylife sciencesbiostatistical analysis for scientific research purposes; providing life science and scientific research information to physicians and other health care professionalspatientsmedicalpharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet developmentdesign and consulting services for otherscreating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and diseasecreating an online community for patients and caregivers to communicate about healthcaredesign and development of interactive computer software for use in the communication and dissemination of medical and pharmaceutical information
Class 44
Providing medical information to physiciansother health care professionals and medical patients; providing health information regarding the medications and health care products of others through e-mail alerts and push notificationsproviding information concerning product discontinuations; providing health information concerning new formulations of medications and health care products of others through e-mail alerts and push notificationsproviding information in the field of pharmaceutical products development; providing health information concerning bottle changes of medications and health care products of others through e-mail alerts and push notificationsproviding information in the field of bottle product designseasonal information in the nature of reports on pharmaceutical products development
Publications
History of USPTO decisions and trademark events.
25 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/04/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/13/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/13/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/13/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/13/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/10/2020
GNFR
FINAL REFUSAL E-MAILED
03/10/2020
CNFR
FINAL REFUSAL WRITTEN
03/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2020
ALIE
ASSIGNED TO LIE
02/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2019
GNRT
NON-FINAL ACTION E-MAILED
08/07/2019
CNRT
NON-FINAL ACTION WRITTEN
08/07/2019
DOCK
ASSIGNED TO EXAMINER
07/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/30/2019
NWAP
NEW APPLICATION ENTERED
05/17/2019
Continuous trademark protection
Get notified about every new filing that threatens BIOPHARMACEUTICAL ACCELERATION MODEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.